Position history for ABN AMRO Bank N.V.'s holdings in VERTEX PHARMACEUTICALS INC
ABN AMRO Bank N.V. holds 155,221 shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $70.1M as of 2025-Q4. The position was increased (++9.4% shares). VRTX represents 0.7% of ABN AMRO Bank N.V.'s portfolio.
Current Value
$70.1M
Current Shares
155,221
Total Value Change
+$16.4M
Total Shares Change
+41,702
Other major holders of VRTX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 155,221 |
+9.4% |
| $70.1M |
| 0.7% |
| $453.74 |
46 |
| 2025-Q3 | Increased | 141,871 | +6.6% | $55.4M | 0.5% | $395.31 | 44 |
| 2025-Q2 | Increased | 133,072 | +4.5% | $59.6M | 0.8% | $441.30 | 43 |
| 2025-Q1 | Increased | 127,393 | +2.7% | $61.7M | 0.9% | $492.69 | 43 |
| 2024-Q4 | Increased | 124,052 | +6.3% | $49.5M | 0.7% | $399.35 | 44 |
| 2024-Q3 | Increased | 116,669 | +2.8% | $53.8M | 0.7% | $462.88 | 43 |
| 2024-Q2 | Increased | 113,519 | +2.0% | $53.7M | 0.8% | $468.72 | 42 |